Renal amyloidosis prediction in kidney disease patients accompanied by monoclonal gammopathy
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70565 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Siyu Bao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Amyloidosis, Kidney Diseases, Paraproteinemias. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: International Science and Technology Cooperation Projects, Shanghai Key Laboratory of Kidney and Blood Purification, Shanghai Science and Technology Commission's New Drug and Medical Device Application Demonstration Project.
Abstract (Originalsprache)
This study aimed to assess whether routine nephrology examinations could predict renal amyloidosis in kidney disease patients with monoclonal gammopathy. A total of 356 consecutive hospitalized patients in the nephrology department with monoclonal gammopathy performed renal biopsies, including 50 renal amyloidosis patients and 306 non‐renal amyloidosis patients, were included after strict filtering. Laboratory and imaging data were collected for each patient. Renal amyloidosis patients exhibited significantly higher 24‐h proteinuria and estimated glomerular filtration rate and decreased serum creatinine (SCr), albumin and immunoglobin M, with lower κ light chain and κ / λ ratio in urine and serum. Higher 24‐h proteinuria and 24‐h microalbuminuria and lower random urine κ / λ ratio, serum κ light chain, serum κ / λ ratio and SCr were significant risk factors for renal amyloidosis. Nomogram model identified albumin, 24‐h urinary microalbumin excretion rate, 24‐h urine κ light chain, 24‐h urine κ / λ ratio and serum IgM as combined predictors of renal amyloidosis (area under the curve 0.781, 95% CI 0.718–0.854). Combined biomarkers (albumin, 24‐h urinary microalbumin excretion rate, 24 h urine κ light chain, 24‐h urine κ / λ ratio and serum IgM) effectively predicted renal amyloidosis in kidney disease patients with monoclonal gammopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Key Laboratory of Kidney and Blood Purification, Shanghai, China.
- Shanghai Medical Center of Kidney, Shanghai, China.
- Shanghai Institute of Kidney and Dialysis, Shanghai, China.
- Department of Hematology, Zhongshan Hospital (Xiamen Branch), Fudan University, Xiamen, Fujian, China.
- Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Siyu Bao, Wensi Bian
Förderung
- International Science and Technology Cooperation Projects
- Shanghai Key Laboratory of Kidney and Blood Purification
- Shanghai Science and Technology Commission's New Drug and Medical Device Application Demonstration Project
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Key Clinical Specialty
Zitieren
APA
Bao, S., Xun, Z., Bian, W., Wang, D., Liu, H., Li, Y., Ding, X., Fang, Y., & Wei, Z. (2026). Renal amyloidosis prediction in kidney disease patients accompanied by monoclonal gammopathy. British Journal of Haematology. https://doi.org/10.1111/bjh.70565
Vancouver
Bao S, Xun Z, Bian W, Wang D, Liu H, Li Y, et al. Renal amyloidosis prediction in kidney disease patients accompanied by monoclonal gammopathy. British Journal of Haematology. 2026. doi:10.1111/bjh.70565
BibTeX
@article{Bao2026,
author = {Bao, Siyu and Xun, Zixuan and Bian, Wensi and Wang, Daxi and Liu, Hong and Li, Yang and Ding, Xiaoqiang and Fang, Yi and Wei, Zheng},
title = {Renal amyloidosis prediction in kidney disease patients accompanied by monoclonal gammopathy},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70565}
}
EUVIMED